Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Radiation Pneumonitis 1

Interventions

nintedanib 2durvalumab 2Radiotherapy 2Immunotherapy 2tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1apatinib 1Tomography, Emission-Computed, Single-Photon 1Prednisone 1Nivolumab 1Nicorandil 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Enalapril 1Disulfides 1Dexamethasone 1Cisplatin 1Breath Holding 1Angiogenesis Inhibitors 1Adrenal Cortex Hormones 1Adjuvants, Immunologic 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiation Pneumonitis × beclomethasone 17-monopropionate × Clear all
NCT03886441 2019-03-26

Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate

Tongji University

Phase 2 Unknown
194 enrolled

Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡